These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14737001)

  • 1. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones.
    Nerurkar PV; Dragull K; Tang CS
    Toxicol Sci; 2004 May; 79(1):106-11. PubMed ID: 14737001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats.
    Lim ST; Dragull K; Tang CS; Bittenbender HC; Efird JT; Nerurkar PV
    Toxicol Sci; 2007 May; 97(1):214-21. PubMed ID: 17329236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
    Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
    Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the alkaloid pipermethystine connected with the claimed liver toxicity of Kava products?
    Lechtenberg M; Quandt B; Schmidt M; Nahrstedt A
    Pharmazie; 2008 Jan; 63(1):71-4. PubMed ID: 18271308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum).
    Jhoo JW; Freeman JP; Heinze TM; Moody JD; Schnackenberg LK; Beger RD; Dragull K; Tang CS; Ang CY
    J Agric Food Chem; 2006 Apr; 54(8):3157-62. PubMed ID: 16608246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperidine alkaloids from Piper methysticum.
    Dragull K; Yoshida WY; Tang CS
    Phytochemistry; 2003 May; 63(2):193-8. PubMed ID: 12711141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23.
    Ma Y; Sachdeva K; Liu J; Ford M; Yang D; Khan IA; Chichester CO; Yan B
    Drug Metab Dispos; 2004 Nov; 32(11):1317-24. PubMed ID: 15282211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular toxicity of kava leaf and root extracts.
    Lüde S; Török M; Dieterle S; Jäggi R; Büter KB; Krähenbühl S
    Phytomedicine; 2008 Jan; 15(1-2):120-31. PubMed ID: 18055189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kava lactones and the kava-kava controversy.
    Whitton PA; Lau A; Salisbury A; Whitehouse J; Evans CS
    Phytochemistry; 2003 Oct; 64(3):673-9. PubMed ID: 13679089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for a kava quality standardization code.
    Teschke R; Lebot V
    Food Chem Toxicol; 2011 Oct; 49(10):2503-16. PubMed ID: 21756963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
    Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
    Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human cytochrome P450 activities by kava extract and kavalactones.
    Mathews JM; Etheridge AS; Black SR
    Drug Metab Dispos; 2002 Nov; 30(11):1153-7. PubMed ID: 12386118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
    Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
    Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.
    Teschke R; Qiu SX; Xuan TD; Lebot V
    Phytother Res; 2011 Sep; 25(9):1263-74. PubMed ID: 21442674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition and biological activity of traditional and commercial kava extracts.
    Côté CS; Kor C; Cohen J; Auclair K
    Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of C-glycoside flavonoids as potential mutagenic compounds in kava.
    Jhoo JW; Ang CY; Heinze TM; Deck J; Schnackenberg LK; Beger RD; Dragull K; Tang CS
    J Food Sci; 2007 Mar; 72(2):C120-5. PubMed ID: 17995826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper methysticum (Kava).
    Liu Y; Lund JA; Murch SJ; Brown PN
    Planta Med; 2018 Nov; 84(16):1213-1218. PubMed ID: 29940660
    [No Abstract]   [Full Text] [Related]  

  • 20. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
    Anke J; Fu S; Ramzan I
    Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.